HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1

Behavior Therapy Clinical Trial

Official title:

HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00084188
• Other study ID #: NIDA-CTN-0019-1
• Status: Completed
• Phase: Phase 3
• First received: June 8, 2004
• Last updated: January 11, 2017
• Start date: May 2004
• Est. completion date: October 2005

Study information

• Verified date: October 2016
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior.

Description:

The proposed trial is intended to test the effectiveness of a proven, manual driven, five-session safer sexual skills building group (SSB) intervention (Schilling et al., 1991; El Bassel and Schilling, 1992) for female patients in MMTP or in drug-free outpatient treatment. The effects of SSB will be compared to a standard group HIV education session (HE).

This study uses a 2-group, randomized, parallel-group design to compare a five-session safer sexual skills building group to a single 60-min HIV education session (control condition). The control condition is designed to standardize and simulate the usual care at community clinics.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 541
• Est. completion date: October 2005
• Est. primary completion date: October 2005
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 99 Years

Eligibility

Adult females (18 years of age or older) in drug abuse treatment at participating Community Treatment Programs are invited to participate.

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

• Behavior Therapy

Intervention

Behavioral:
• Behavior Therapy

Locations

Country	Name	City	State
United States	LRADAC-Lexington-Richmond Alcohol & Drug Council	Columbia	South Carolina
United States	Addiction Drug Services	Greensboro	North Carolina
United States	Prestera Center for Mental Health Svcs.	Huntington	West Virginia
United States	Baart Cdp	Los Angeles	California
United States	Hartford Dispensary	New Britain	Connecticut
United States	The Consortium	Philadelphia	Pennsylvania
United States	Thomas Jefferson Intensive Sub. Abuse TP	Philadelphia	Pennsylvania
United States	South Light - Life Plus	Raleigh	North Carolina
United States	South Light - Wakeview	Raleigh	North Carolina
United States	Evergreen Treatment Services	Seattle	Washington
United States	Staten Island University Hospital	Staten Island	New York
United States	Comprehensive Addiction Services System	Toledo	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
New York State Psychiatric Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	AIDS risk behavior